First CpG island microarray for genome-wide analyses of DNA methylation in Chinese hamster ovary cells: new insights into the epigenetic answer to butyrate treatment by Anna Wippermann et al.
ORAL PRESENTATION Open Access
First CpG island microarray for genome-wide
analyses of DNA methylation in Chinese hamster
ovary cells: new insights into the epigenetic
answer to butyrate treatment
Anna Wippermann1,2*, Sandra Klausing1, Oliver Rupp2, Thomas Noll1,2, Raimund Hoffrogge1
From 23rd European Society for Animal Cell Technology (ESACT) Meeting: Better Cells for Better Health
Lille, France. 23-26 June 2013
Background
Optimizing productivity and growth of recombinant
Chinese hamster ovary (CHO) cells requires insight and
intervention in regulatory processes. This is to some
extent accomplished by several ‘omics’ approaches. How-
ever, many questions remain unanswered and bioprocess
development is therefore still partially empirical. In this
regard, the analysis of DNA methylation as one of the
earliest cellular regulatory levels is increasingly gaining
importance. This epigenetic process is known to influ-
ence transcriptional events when it occurs at specific
genomic regions with high CpG frequencies, called CpG
islands (CGIs). Being methylated, CGIs attract proteins
with methyl-DNA binding domains (MBD proteins) that
in turn can interact with chromatin modifying com-
plexes, thereby leading to a transcriptionally inactive
state of the associated gene [1]. In CHO cells, DNA
methylation has yet only been investigated in gene-specific
approaches, e.g. regarding the CMV promoter [2]. To ana-
lyze differential DNA methylation in CHO cultures on a
genomic scale, we developed a microarray covering 19,598
CGIs in the CHO genome. We applied it to elucidate the
effect of butyrate on CHO DP-12 cultures, as this short
chain fatty acid (SCFA) is known to elicit epigenetic
responses by inhibiting histone-deacetylases [3].
Materials and methods
Based on the genomic and transcriptomic information
available for CHO cells [4,5], 21,993 promoter-associated
and intragenic CGIs were identified in the CHO genome
using an algorithm according to Takai and Jones [6]. We
developed a customized 60K microarray (printed by
Agilent Technologies) covering 19,598 (89%) of the iden-
tified CGIs with an average probe spacing of 500 bp.
Genomic DNA of each four replicate experimental and
reference CHO DP-12 (clone #1934, ATCC CRL-12445)
batch cultures was phenol-chloroform extracted and
sheared by sonication. Methylated fragments were
enriched using the methyl-CpG binding domain of
MBD2 protein fused to the Fc tail of IgG1 (MBD2-Fc
protein) coupled to magnetic beads (New England Bio-
labs). Experimental samples prior to treatment with 3
mM butyrate (0 h) as well as 24 hours and 48 hours after
butyrate addition were directly compared to the refer-
ences by two-colour co-hybridizations. Data analysis was
carried out upon LOWESS normalization by Student’s
t-tests with p-values ≤ 0.05 using the open source platform
EMMA2 [7]. Confirmatory COBRA (combined bisulfite
restriction analysis) was performed by amplifying a 541 bp
fragment of the myc proto-oncogene protein-like gene
(Gene ID: 100758352) following bisulfite treatment of
genomic DNA using the primers myc_for 5’-atttggaagga-
tagtaagtatattggaag-3’ and myc_rev 5’- aaataaaactctaactcac-
catatctcct-3’ and the nested primers myc_for_nested
5’- atagtaagtatattggaaggggagtg-3’ and myc_rev_nested
5’- taaaactctaactcaccatatctcctc-3’ (oligonucleotides obtained
from Metabion). Purified PCR products were digested with
BstUI (Fermentas) and separated in agarose gels.
Results
Butyrate treated CHO DP-12 cultures stopped proliferat-
ing and decreasing viabilities could be detected 24 hours
upon addition of the SCFA (Figure 1A). Simultaneously,
* Correspondence: anna.wippermann@uni-bielefeld.de
1Cell Culture Technology, Bielefeld University, Bielefeld, Germany
Full list of author information is available at the end of the article
Wippermann et al. BMC Proceedings 2013, 7(Suppl 6):O5
http://www.biomedcentral.com/1753-6561/7/S6/O5
© 2013 Wippermann et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
cell specific productivities increased by nearly 100 %
(17 pg/cell/day 48 hours after butyrate addition compared
to 9 pg/cell/day in the reference cultures). Surprisingly,
228 differentially methylated genes could be detected in a
comparison between the experimental cultures and the
references even before addition of butyrate (Figure 1B),
indicating substantial heterogeneity among identically
handled parallel cultivations. 24 hours after butyrate addi-
tion we found a strongly increased number of 1221, solely
at this point in time, differentially methylated genes. Gene
ontology classification showed that, amongst others, the
terms ‘stress response’, ‘chromatin modification’ or ‘signal-
ling cascade’ were significantly overrepresented. Pathways
such as the Ca2+, MAPK and Wnt signalling systems were
comprised within the latter group and showed a large cov-
erage by differentially methylated components. 48 hours
upon butyrate addition the number of differential methyla-
tions decreased by about 90 %. COBRA analysis of the
Wnt responsive myc proto-oncogene protein-like gene
showed clearly detectable cleavage products (indicating
methylation of the BstUI sites in the original DNA) 24
hours upon butyrate addition, that completely vanished
another 24 hours later (Figure 1C), confirming the results
of the microarray analysis.
Conclusions
Our first genome-wide screening for differential DNA
methylation in CHO cells shows that the epigenetic
response upon butyrate treatment seems to be highly
dynamic and reversible. This was confirmed by applying
the bisulfite-based single-gene method COBRA to analyze
a region of the myc proto-oncogene protein-like gene.
Furthermore, detection of differential methylation before
butyrate addition indicates that heterogeneity in DNA
methylation occurs even if cells originated from the same
preculture and were treated identically. This occurrence of
differentially methylated genes in parallel cultivations
strongly fosters the hypothesis that the culture history
influences final process outcomes [8]. It underlines the
importance of DNA methylation analyses in CHO cells,
Figure 1 (A) Viable cell densities, viabilities and cell specific productivities for batch CHO DP-12 reference (blue) and butyrate treated
(red) cultivations. The green dashed line marks the point of butyrate addition. Error bars represent standard deviations. (B) Venn diagram
showing the numbers of genes associated with differentially methylated CpG islands before (0 h), 24 hours and 48 hours upon butyrate
addition. Gene Ontology classification was performed using DAVID [9] with an EASE score ≤ 0.01 (C) COBRA analysis of a part of the CGI (blue)
of the myc proto-oncogene protein-like gene (green) differential methylation was detected for (red). Cleavage products indicate methylation of
BstUI sites in the original DNA.
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especially considering the fact that DNA methylation pat-
terns can remain stably anchored over several generations.
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